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ABSTRACT
Granulocyte-macrophage colony stimulating factor
(GM-CSF) plays a key role in myeloid cell func-
tion and is rapidly and transiently expressed in T
cells in response to immune or inflammatory stimuli.
Induction of GM-CSF gene expression is accom-
panied by changes in chromatin structure across
the proximal promoter region of the gene. We show
that the promoter remodelling and subsequent gene
transcription occurs with distinct signal and trans-
cription factor requirements. Activation of the protein
kinase C (PKC) signalling pathway is sufficient to
induce changes in chromatin structure across the
promoter, but both the PKC and calcium signalling
pathways are required for efficient gene transcription.
Although NFAT transcription factors contribute
to GM-CSF gene transcription, they are not required
for promoter remodelling. However, the presence of
the nuclear factor-kB transcription factor, c-Rel, in the
nucleus is strongly correlated with and required
for the events of chromatin remodelling.
INTRODUCTION
Activation of T cells by antigen results in the expression of a
range of cytokines, which are important for the orchestration
of an immune response. Generally, the genes encoding these
cytokines are maintained in a transcriptionally silent state, and
are rapidly but transiently expressed following T cell receptor
stimulation. Induction of cytokine gene expression is con-
trolled largely at the level of transcription, by the assembly
of specific transcription factor complexes at the promoter and
enhancer regions of the genes (1,2). However, within the cell
nucleus, genes are found assembled into chromatin and it is
now clear that chromatin can provide an additional level of
control, by regulating the accessibility of the promoter to the
transcription machinery [reviewed in (3,4)].
A number of studies have clearly demonstrated that
changes in chromatin structure accompany induction of cyto-
kine gene transcription in response to immune stimulation
(5–9). However, the exact sequence of events, which leads
to chromatin remodelling and subsequent gene activation is
understood in detail for only a small number of eukaryotic
genes, most notably, the induction of the yeast Pho5 gene in
response to low phosphate (10) and the IFNb gene following
viral infection (11). An emerging theme is that gene-specific
changes in the chromatin structure can be generated following
the recruitment of chromatin modifying activities to gene
promoters by DNA bound transcription factors (12,13). In
the case of IFNb, gene expression in response to viral
infection is initiated by the assembly of transcription factors
into a highly organized enhanceosome complex on the nucleo-
some-free enhancer region of the gene (11). Chromatin modi-
fying activities are then recruited by the enhanceosome to
remodel an adjacent nucleosome, facilitating gene transcrip-
tion (14). The Pho5 gene is activated in low-phosphate con-
ditions by the binding of the Pho4 activator to a binding site in
a nucleosome-free region. This facilitates the remodelling of
adjacent nucleosomes, allowing the binding of additional tran-
scription factors and gene activation (10,15). These remodel-
ling events are a prerequisite for gene activation (16,17).
However for many genes, such as those encoding the cytokines
GM-CSF, IL-2 and IL-12, the transcription factor binding sites
in the promoter regions of these genes are not found in nucleo-
some-free regions but appear to be assembled into nucleo-
somes (6,8,9). While chromatin remodelling has been found
to accompany the activation of these cytokine genes following
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immune stimulation, the mechanisms involved remain to be
elucidated.
GM-CSF plays an important role in the orchestration of an
immune or inflammatory response (18). It is expressed in a
variety of cell types, including T cells in response to immune
or inflammatory stimuli. In T cells, GM-CSF expression is
rapidly, but transiently induced following T cell receptor liga-
tion and costimulation through the CD28 co-receptor (19).
Induction of GM-CSF gene expression is regulated by a
proximal promoter limited to 100 bp upstream of the transcrip-
tion start site as well as an upstream enhancer [reviewed in
(1)]. The proximal promoter consists of an array of transcrip-
tion factor binding sites including sites for nuclear factor-kB
(NF-kB) family members located within the CD28 response
region (CD28RR) of the promoter and an adjacent region
containing binding sites for a number of transcription factors,
including NFAT and AP-1 (20,21).
Induction of GM-CSF gene expression upon T cell
activation is accompanied by changes in chromatin structure
across the GM-CSF promoter (7,9,22). A region of <200 bp
encompassing the promoter becomes increasingly accessible
upon T cell activation, suggesting the targeted remodelling of
a single nucleosome (9). The chromatin remodelling events
precede GM-CSF gene transcription and similar to gene tran-
scription, are dependent on the presence of NF-kB proteins
(9,21,22).
Here, we show that chromatin remodelling events
across the GM-CSF promoter and GM-CSF gene transcription
are distinct molecular events, which occur with distinct
kinetics and have different signal and transcription factor
requirements.
MATERIALS AND METHODS
Plasmids
The mouse GM-CSF construct, AOGM, was provided by
Dr P. Cockerill and has been described previously (23). A
mouse GAPDH–PCR plasmid, containing a 67 bp fragment
of the mouse GAPDH cDNA was generated by cloning a
PCR product amplified using the primers outlined below
into pCR 2.1 (Invitrogen).
Cell culture
EL-4 T cells were cultured in RPMI as described previously
(8). Cells were stimulated with 20 ng/ml of PMA (P)
(Boehringer Mannheim) and 1 mM of calcium ionophore (I)
(A23187; Sigma–Aldrich). Cells were pre-treated with inhi-
bitors before stimulation as follows: 10 mg/ml of cyclohexa-
mide (Calbiochem) for 30 min; 50 mg/ml of cyclosporin
(Calbiochem) for 30 min; 10 mM of Ro-32-0432 (Roche)
for 1 h; and 1–6 mg/ml of pentoxifylline (Sigma) for 30 min.
Primary T cell preparation
All mice were maintained in a pathogen-free environment in a
barrier facility. Spleens were isolated from C57BL/6 mice and
c-rel/ mice (4–5 weeks old) and CD4+ T cells purified using
MACS CD4+ beads, according to the manufacturer’s instruc-
tions (Miltenyi Biotech). The cells were stained and analysed
by flow cytometry with T cell populations demonstrated to be
90% CD4+. Cells were stimulated with P and I as described
above and with an activating CD28 antibody (BD Phar-
Mingen) at 5 mg/ml. Anti-CD3 stimulation was performed
by coating the plates with 10 mg/ml of anti-CD3 antibody
(BD PharMingen) at 37C for 4 h. The plates were washed
with phosphate-buffered saline (PBS) before the addition of
cells at a density of 1.25 · 106 cells/ml.
Nuclear extracts and western blotting
Nuclear extracts were prepared after a modification in the
method of Schreiber et al. (24). Briefly, EL-4 T cells at a
density of 5 · 105 cells/ml were centrifuged for 5 min at
500 g, washed with PBS, resuspended in 1 ml of ice-cold
Buffer A (10 mM Tris, pH 7.4, 10 mM NaCl, 3 mM
MgCl2, 0.1 mM EDTA and 0.5% NP-40, containing protease
inhibitors) per 5 · 106 cells, and incubated on ice for 5 min.
Nuclei were recovered by centrifugation at 900 g for 5 min,
washed in Buffer A without NP-40, resuspended in 75 ml
Buffer C (400 mM NaCl, 7.5 mM MgCl2, 0.2 mM EDTA,
0.1 mM EGTA, 1 mM DTT and protease inhibitors) per 5 · 107
cells and incubated on ice with shaking for 15 min. Nuclear
debris was removed by centrifugation at 13 000 g for 5 min.
Protein concentrations were determined by Bradford Assay
(Bio-Rad).
Proteins were resolved by SDS–PAGE through 12% poly-
acrylamide, transferred onto nitrocellulose membrane and
subjected to western-blot analysis using anti-RelA, anti-c-
Rel, anti-NFATp, anti-NFATc and anti-Sp1 antibodies
(Santa Cruz) and the corresponding peroxidase-conjugated
secondary antibodies (DAKO). Proteins were visualized
using the Supersignal West Pico Chemiluminescent kit
(Pierce), according to the manufacturer’s instructions.
RNA isolation and real-time PCR analysis
Total RNA was isolated using Tri-Reagent (Sigma) and
reverse transcribed using Superscript II Reverse Transcriptase
(Life Technologies), as described previously (9). SYBR Green
PCR amplification was performed on the Rotor-Gene 2000
real-time cycler (Corbett Research) using the QuantiTect
SYBR Green PCR kit (Qiagen), according to the manufac-
turer’s instructions in a total volume of 25 ml, containing 50 ng
of cDNA. Cycling conditions were as follows: 95C for
15 min; 95C for 15 s, 60C for 1 min for 35 cycles, acquiring
on channel 1, followed by melt analysis from 60 to 95C.
The GM-CSF primers used were as follows:
GM-CSF for, 50-AAGGGTCCTGAGGAGGATGTG-30;
GM-CSF rev, 50-GAGGTTCAGGGCTTCTTTGA-30.
PCR reactions were conducted in parallel to normalize
for differences in cDNA synthesis and RNA input, using
the following primers:
GAPDH for, 50-AAGTATGATGACATCAAGAAGGTG-
GT-30;
GAPDH rev, 50-AGCCCAGGATGCCCTTTAGT-30.
To correlate the threshold (Ct) values from the amplification
plots to copy number, a standard curve was generated using
the mouse GM-CSF plasmid AOGM and pCR2.1–GAPDH
plasmid. PCR product melt curves were analysed for a
single peak and the products were visualized by agarose gel
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electrophoresis and ethidium bromide staining to ensure that a
single product was generated in the PCR.
Chromatin accessibility by real-time PCR
Accessibility of DNA to digestion with restriction enzymes
and micrococcal nuclease (MNase) was analysed using chro-
matin accessibility by real-time PCR (CHART–PCR) (8).
EL-4 T cell nuclei (5 · 106 nuclei per 100 ml) were treated
with 150 U of HinfI enzyme (New England BioLabs) at 37C
for 45 min or with 25 U of MNase (Boehringer) for 5 min at
20C, as determined empirically. In each case, control samples
without the enzyme were incubated in a similar manner to
monitor for endonuclease activity. Genomic DNA was subse-
quently isolated using a QIAamp blood kit (Qiagen), accord-
ing to the manufacturer’s instructions. Genomic DNA (50 ng)
was analysed by SYBR Green real-time PCR in a total volume
of 25 ml, using the QuantiTect SYBR Green PCR kit (Qiagen),
according to the manufacturer’s instructions. The primer sets
used were as follows:
setI For, 50-GCCTGACAACCTGGGGGAAG-30;
setI Rev, 50-TGATTAATGGTGACCACAGAACTC-30;
set+I For, 50-GAGTTCTGTGGTCACCATTAATCA-30; and
set+I Rev, 50-CACATCCTCCTCAGGACCTT-30,
as described previously (9). Accessibility was determined by
correlating the Ct values from the amplification plots to a
standard curve generated with the AOGM plasmid, and was
expressed as a percentage of undigested genomic DNA for
each primer set.
RESULTS
Distinct signals are required for chromatin remodelling
and gene transcription at the GM-CSF promoter
Upon T cell activation, changes in the chromatin structure
occur across the GM-CSF promoter and are limited to the
region between 174 and +24, suggesting the remodelling
of a single nucleosome encompassing the proximal promoter
(9). To determine the relationship between the signal require-
ments for GM-CSF promoter remodelling and gene transcrip-
tion, these processes were examined following the activation
of different intracellular signalling pathways in T cells. T cell
receptor ligation results in the activation of two major intra-
cellular signal pathways involving mobilization of protein
kinase C (PKC) and increases in free intracellular calcium
levels, which can be mimicked by treatment of cells with
either P or I, respectively. Therefore, murine EL-4 T cells
were either left unstimulated or stimulated with P, I or both
(P/I) for 4 h. Following the stimulation, the accessibility of
the GM-CSF promoter to micrococcal nuclease (MNase) or
restriction enzyme digestion was measured by a real-time PCR
assay [CHART–PCR, (8)] using primer sets, which span the
GM-CSF promoter [Figure 1A and (9)]. Accessibility of a
HinfI site in the CD28RR of the GM-CSF promoter
(at 97) was assessed using primer set I (155 to 40,
Figure 1A), which spans the CD28RR. PCR amplification
was monitored by SYBR green incorporation and the amount
of PCR product generated from digested samples was plotted
as a percentage of the amount generated from undigested
genomic DNA samples. As described previously (9), in
unstimulated cells, the HinfI site in the promoter displayed
an inherent accessibility to restriction enzyme digestion
(Figure 1B) and the accessibility increased significantly
upon stimulation with P/I. While stimulation with I alone
had no effect on the accessibility of the HinfI site, stimulation
with P alone increased accessibility to the levels seen with P/I
combined (Figure 1B). To determine whether the accessibility
changes at the HinfI site were also seen across the entire
promoter, the effect of the different stimuli on the accessibility
of the promoter region to MNase digestion was assessed using
primer set I, which covers the CD28RR and primer set +I
(63 to +44), which covers the adjacent NFAT/AP-1 region
(Figure 1A). In unstimulated cells, both the CD28RR and the
NFAT/AP-1 region displayed an inherent accessibility to
MNase, which increased following stimulation with P/
I or with P alone (Figure 1C and D). However, no increase
in accessibility was detected following treatment with I alone
(Figure 1C and D).
To compare the changes in chromatin structure across the
GM-CSF promoter with gene transcription, GM-CSF mRNA
levels were analysed by quantitative real-time PCR analysis of
RNA isolated from EL-4 T cells. While treatment with P alone
induced GM-CSF gene transcription (20-fold) and a dramatic
increase in mRNA (200-fold) was detected in cells stimu-
lated with P/I for 4 h (Figure 1E), little increase in mRNA
levels was detected in cells treated with I alone (4-fold).
Therefore, while the signals generated from treatment of
cells with P alone are sufficient to induce changes in chromatin
structure at the GM-CSF promoter, signals generated by I
cooperate with P signals to lead to high levels of GM-CSF
gene transcription.
To confirm that the PKC signalling pathway is required for
chromatin changes at the GM-CSF promoter, EL-4 T cells were
pre-treated with the PKC inhibitor Ro32-0432 and then either
left unstimulated or stimulated with P/I for 4 h and the access-
ibility of the HinfI restriction site was assessed by CHART–
PCR. Pre-treatment with the PKC inhibitor, prevented chro-
matin remodelling in response to P/I stimulation (Figure 2A).
In contrast, pre-treatment of cells with cyclosporin A (CsA),
which inhibits the calcium signalling pathway (25), had no
impact on chromatin remodelling at the Hinf1 site in the
GM-CSF promoter in response to P/I stimulation (Figure
2B). In contrast to their differential effects on chromatin re-
modelling, both Ro32-0432 and CsA reduced but did not com-
pletely inhibit the accumulation of GM-CSF mRNA in response
to P/I (Figure 2C and D), which agrees with the partial impact of
each of these signals on transcription (Figure 1E).
Therefore, the PKC pathway appears to be necessary and
sufficient for chromatin remodelling across the GM-CSF pro-
moter, while the calcium signalling pathway is not required
for chromatin remodelling events but contributes to efficient
GM-CSF gene transcription.
The presence of NF-kB proteins in the nucleus
correlates with chromatin remodelling events
The GM-CSF proximal promoter contains an array of binding
sites for the related transcription factor families NF-kB and
NFAT, which have distinct but overlapping signal require-
ments. These transcription factors have been previously
implicated in promoter function [Figure 1A and (20,21,26)],
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and we have shown that chromatin remodelling was dependent
on NF-kB proteins (9). However, it was not clear if this was a
unique role or if other transcription factor families, such as
NFAT also contributes to chromatin remodelling. Therefore,
western-blot analysis was used to correlate the nuclear activa-
tion of both NFAT and NF-kB factors with promoter access-
ibility and gene transcription. Nuclear extracts were prepared
from unstimulated cells and cells treated with P, I and P/I for
4 h. As expected, RelA, c-Rel, NFATc and NFATp proteins
were translocated to the nucleus following stimulation with P/I
(Figure 2E). Treatment with I led to a low-level nuclear
accumulation of NFATc alone, whereas treatment with P
alone caused a nuclear accumulation of RelA, c-Rel and
NFATc, but not NFATp (Figure 2E). Nuclear levels of the
Sp1 protein, which is known to be constitutively present in the
nucleus, were constant in all extracts, demonstrating equal
protein loading in each lane (Figure 2E).
A primary target of CsA is the calcium/calmodulin-
dependent phosphatase calcineurin, which regulates NFAT
translocation to the nucleus and as expected, accumulation
of NFATp and NFATc in the nucleus, following stimulation
with P/I for 4 h is inhibited in cells pre-treated with CsA
(Figure 2F). In contrast, CsA pre-treatment reduces, but does
not completely inhibit nuclear translocation of the NF-kB
proteins, RelA and c-Rel (Figure 2F). On the other hand,
the inhibitor of the PKC pathway, Ro32-0432 prevented
nuclear accumulation of all of these proteins, although there
was a residual amount of RelA seen in the nucleus (Figure 2G).
Taken together, there is a clear correlation between chro-
matin remodelling at the GM-CSF promoter, activation of the
PKC signalling pathway and the presence of NF-kB proteins,
but not NFAT proteins, in the nucleus. However, NFAT pro-
teins appear to contribute to GM-CSF transcription and mRNA
accumulation.
Protein synthesis is required for chromatin
remodelling at the GM-CSF promoter
We have shown previously that chromatin remodelling at
the GM-CSF promoter required at least 1 h to occur and
was stable over a 6 h period (9). These delayed kinetics raised
the possibility that new protein synthesis might be required for
Figure 1. Distinct signals are required for chromatin remodelling at the GM-CSF promoter and GM-CSF gene transcription. (A) Schematic representation of the GM-
CSF promoter showing transcription factor binding sites and the CD28RR. DNA fragments amplified by PCR primer setsI and +I and the HinfI restriction enzyme
site are shown. (B) Nuclei from non-stimulated EL-4 T cells (NS) or cells stimulated for 4 h with P, I or P/I as indicated, were incubated with HinfI. Genomic DNA was
analysed by real-time PCR using primer set I. The mean and standard error of three replicate assays are shown. (C and D) Nuclei from cells treated as in (B) were
incubated with MNase and genomic DNA was analysed using primer setI (C) or primer set +I (D). (E) GM-CSF mRNA levels were determined by real-time PCR
analysis of cDNA prepared from EL-4 T cells treated as in (B). Data were graphed as a fold change in the mRNA levels compared with NS.
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this event. The various NF-kB and NFAT proteins can also be
distinguished by their requirement for new protein synthesis
(27,28). Pre-treatment of EL-4 T cells with the translation
inhibitor cyclohexamide inhibited chromatin remodelling
at the promoter in response to P/I (Figure 3A), demonstrating
that new protein synthesis is required for chromatin changes
at the promoter. However, GM-CSF gene transcription still
occurred in the presence of cyclohexamide and in the
absence of chromatin remodelling, although at reduced levels
(Figure 3B). In addition, c-Rel but not RelA nuclear
accumulation was dependent on new protein synthesis
(Figure 3C). Similarly, NFATp, which pre-exists in the cyto-
plasm of unstimulated cells (28), but not NFATc, which is
synthesized de novo, accumulated in the nucleus of cells pre-
treated with cyclohexamide following stimulation.
These data show that chromatin remodelling requires new
protein synthesis and implicates proteins, such as c-Rel and
NFATc, in this process. It should also be noted that gene
transcription can proceed even in the absence of any detectable
chromatin remodelling.
Figure 2. The PKC, but not the calcium signalling pathway is required for chromatin remodelling of the GM-CSF promoter. (A) EL-4 T cells were either left
untreated or pre-treated with Ro32-0432, then incubated with or without P/I for 4 h, as indicated. Nuclei were incubated with HinfI and the genomic DNA analysed by
real-time PCR using primer set I. The mean and standard error of three replicate assays are shown. (B) EL-4 T cells were either untreated or pre-treated with
cyclosporin A (CsA), then incubated with or without P/I for 4 h, as indicated. Nuclei were incubated with HinfI and the genomic DNA analysed as in (A). (C) GM-CSF
mRNA levels were determined by real-time PCR analysis of cDNA prepared from EL-4 T cells treated as in (A). Data were graphed as a fold change in the mRNA
levels compared with unstimulated, untreated cells. The mean and standard error of three replicate assays are shown. (D) GM-CSF mRNA levels were determined by
real-time PCR analysis of cDNA prepared from EL-4 T cells treated as in (B). Data were graphed as a fold change in the mRNA levels compared with unstimulated,
untreated cells. (E) Nuclear extracts from non-stimulated EL-4 T cells (NS) or cells stimulated with P, I or P/I for 4 h were subjected to SDS–PAGE and analysed by
western blotting with the indicated antibodies. (F) Nuclear extracts were isolated from untreated cells or cells pre-treated with CsA, then incubated for 4 h with or
without P/I. Extracts were analysed as in (E). (G) Nuclear extracts were isolated from untreated cells or cells pre-treated with Ro32-0432, then stimulated for 4 h with
P/I. Extracts were analysed as in (E).
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The stability of GM-CSF promoter remodelling
We have shown previously that GM-CSF mRNA accumula-
tion followed the event of chromatin remodelling at the pro-
moter (7) but do not know if transcription levels and chromatin
accessibility follow similar kinetics over longer time frames.
Following P/I stimulation of EL-4 T cells, the GM-CSF
mRNA levels increased to 600-fold, 6 h after stimulation
(Figure 4A), but had decreased significantly by 24 and 48 h,
post-stimulation. This decrease is probably a combination of
reduced gene transcription as well as increased mRNA instab-
ility [reviewed in (18)]. The GM-CSF promoter displayed an
increased accessibility to HinfI and MNase digestion within
2 h of stimulation with P/I, and was maintained at maximal
levels for up to 24 h (Figure 4B and C). At 48 h post-
stimulation HinfI accessibility had decreased to some extent,
but the promoter still displayed maximal accessibility to
MNase (Figure 4B and C).
Therefore, while GM-CSF gene transcription occurs
transiently following T cell activation, GM-CSF promoter
remodelling is more stable, with the promoter maintained in
an accessible state for >48 h post-stimulation.
To determine whether the maintenance of a remodelled state
at the GM-CSF promoter requires persistent stimulation, the
cells were stimulated with P/I for 2 h, which gives sufficient
time to induce changes in chromatin accessibility (Figure 4B
and C), and the stimulus then removed for various times. After
stimulus removal GM-CSF mRNA levels declined by 4 h and
returned to basal levels within 22 h (Figure 4D). In contrast,
following stimulus withdrawal, the accessibility of the HinfI
site in the promoter was maintained at near maximal levels for
at least 4 h, but by 22 h it was decreased by 50% (Figure 4E).
Accessibility to MNase was also examined over an extended
time course. Cells were stimulated for 2 h with P/I to facilitate
complete chromatin remodelling (Figure 4C) and then
incubated for up to 72 h either in the presence of P/I or fol-
lowing stimulus withdrawal. In the continual presence of P/I
stimulation, promoter accessibility was maintained for 48 h,
and although decreasing by 72 h, had still not returned to basal
levels (Figure 4F). In contrast, if the stimulus was withdrawn
at 2 h, accessibility decreased within 22 h, and had returned
to basal levels 46 h after stimulus withdrawal. Therefore,
the remodelled GM-CSF promoter returns to its basal state
following stimulus withdrawal but with significantly delayed
kinetics compared to mRNA levels.
Chromatin remodelling across the promoter is induced by
stimulation with P, but additional signals generated by the
treatment of cells with I are required to induce significant
transcription (Figure 1). To determine whether these stimuli
are both required for transcriptional activation once chromatin
changes are induced, cells were stimulated for 2 h, then the
stimulus withdrawn for 22 h to allow the mRNA levels, but not
the chromatin accessibility to return to basal levels. Cells were
then either left unstimulated or restimulated with P, I or P/I
(Figure 4G). While a small increase in the GM-CSF mRNA
levels was detected upon stimulus with P alone, both P and I
were required to induce a significant increase in the mRNA
levels. Therefore, the signals generated by treatment of cells
with P are required to induce chromatin remodelling events
across the promoter, but are also required to induce GM-CSF
transcriptional activation.
The kinetics of transcription factor activation in the nucleus
was then compared with those of chromatin remodelling. As
expected, RelA and NFATp were translocated to the nucleus
rapidly following stimulation and, mirroring the GM-CSF
mRNA levels (Figure 4A), had returned to near basal levels
by 24 h post-stimulation (Figure 4H). In contrast, c-Rel and
NFATc accumulation in the nucleus occurred more slowly and
were still present in the nucleus for up to 24 h (Figure 4H). If
the presence of c-Rel and/or NFATc in the nucleus is required
for the maintenance of the remodelled state, then these pro-
teins may persist following stimulus withdrawal. If the stimu-
lus is removed after 2 h, RelA levels decrease dramatically
within 4 h and are completely depleted within 22 h (Figure 4I),
mirroring GM-CSF transcription events (Figure 4D). Simi-
larly, both NFATp and NFATc are present in the nucleus
6 h post-stimulation but are depleted from the nucleus rapidly
following stimulus withdrawal (Figure 4I). However, the c-Rel
levels in the nucleus are maintained 4 h after stimulus removal,
and although at somewhat reduced levels, are still evident in
the nucleus, 22 h after stimulus withdrawal (Figure 4I). There-
fore, the nuclear accumulation of c-Rel is the most stable of
these proteins.
Figure 3. Protein synthesis is required for chromatin remodelling but not transcription at the GM-CSF promoter. (A) EL-4 T cells were either untreated or pre-treated
with cyclohexamide (CHX), then incubated with or without P/I for 4 h, as indicated. Nuclei were incubated with HinfI and the genomic DNA analysed by real-time
PCR using primer setI. The mean and standard error of three replicate assays are shown. (B) GM-CSF mRNA levels were determined by real-time PCR analysis of
cDNA prepared from EL-4 T cells treated as in (A). Data were graphed as a fold change in the mRNA levels compared with NS. (C) Nuclear extracts from cells treated
as in (A), were subjected to SDS–PAGE and analysed by western blotting with the indicated antibodies.
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Figure 4. GM-CSF promoter remodelling and gene transcription display distinct kinetics. (A) GM-CSF mRNA levels were determined by real-time PCR analysis of
cDNA prepared from EL-4 T cells stimulated with P/I for the indicated time periods. The mean and standard error of three replicate assays are shown. (B and C) Nuclei
from cells stimulated with P/I for the indicated time periods, were incubated with HinfI (B) or MNase (C). Genomic DNA was analysed by real-time PCR using primer
setI. The mean and standard error of three replicate assays are shown. (D) EL-4 T cells were either left unstimulated or stimulated with P/I for 2 h, then the stimulus
was withdrawn and the cells incubated for the indicated time periods. GM-CSF mRNA levels were determined by real-time PCR analysis of cDNA prepared from
cells harvested at the indicated time points. The mean and standard error of three replicate assays are shown. (E and F) Nuclei were isolated from the cells treated as in
(D) for the time periods indicated, then incubated with HinfI (E) and MNase (F). Genomic DNA was analysed by real-time PCR using primer set I. The mean and
standard error of three replicate assays are shown. (G) EL-4 T cells were either left unstimulated or stimulated with P/I for 2 h as indicated, then the stimulus
withdrawn for 22 h. Cells were then either left unstimulated (NS) or restimulated for 4 h with P, I or PI. GM-CSF mRNA levels were determined by real-time PCR
analysis of cDNA prepared from the cells. The mean and standard error of three replicate assays are shown. (H) Nuclear extracts were prepared from either
unstimulated EL-4 T cells or cells stimulated with P/I for the indicated time periods and analysed by western blotting with the indicated antibodies. (I) EL-4 T cells
were either left unstimulated or stimulated with P/I for 2 h, then the stimulus was withdrawn and the cells were incubated for the indicated time periods. Nuclear
extracts were prepared and analysed by western blotting with the indicated antibodies.
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Thus, the presence of c-Rel correlates with the more stable
kinetics of chromatin remodelling and with the ability to main-
tain chromatin accessibility following stimulus withdrawal.
c-Rel is required for chromatin remodeling events
at the GM-CSF promoter
Chromatin remodelling events at the GM-CSF promoter cor-
relate with the presence of NF-kB proteins, and c-Rel in par-
ticular, in the cell nucleus. To investigate the requirement for
c-Rel, cells were pre-treated with pentoxifylline before stimu-
lation with P/I for 4 h. Treatment of cells with 6 mg/ml of
pentoxifylline inhibited c-Rel but not RelA nuclear accumu-
lation (29) (Figure 5A). This concentration of pentoxifylline
also inhibited nuclear accumulation of NFATc but not NFATp
(Figure 5B). Pre-treatment with pentoxifylline inhibited chro-
matin remodelling at the GM-CSF promoter in response to P/I
stimulation (Figure 5C), implicating c-Rel in GM-CSF pro-
moter remodelling. While the nuclear activation of NFATc
was also inhibited under these conditions, the NFAT proteins
were previously found not to contribute to promoter remod-
elling events (Figure 2). GM-CSF transcription still occurred
in pentoxifylline-treated cells although at reduced levels
(Figure 5D). This parallels the observations made in the pres-
ence of cyclohexamide.
Induction of GM-CSF gene expression is impaired in the
T cells from c-Rel/ mice (30). To determine whether chro-
matin remodelling events at the GM-CSF promoter are also
impaired in c-Rel/ mice, HinfI accessibility of the GM-CSF
promoter was examined in the CD4+ T cells isolated from
wild-type or c-Rel/ mice. While an increase in accessibility
was detected in wild-type T cells following stimulation with
P/I and anti-CD28 antibodies, no change in accessibility was
detected in the T cells from c-Rel/ mice (Figure 5E).
Similarly, the stimulation of wild-type T cells with anti-
CD3/anti-CD28 antibodies resulted in an increased promoter
accessibility to MNase (Figure 5F), and while the basal
accessibility to MNase was higher in the unstimulated T
cells from c-Rel/ mice, no increased accessibility was
observed following stimulation (Figure 5F). Thus, these
data clearly demonstrate that c-Rel is required for GM-CSF
promoter remodelling in response to T cell stimulation.
DISCUSSION
Upon T cell activation, induction of GM-CSF gene transcrip-
tion is accompanied by changes in chromatin accessibility
across the proximal promoter (7,9,22). These changes are
limited to a region of <200 bp, suggesting the remodelling
Figure 5. c-Rel is required for GM-CSF promoter remodeling. (A and B) Nuclear extracts were prepared from EL-4 T cells pre-treated with the indicated
concentrations of pentoxifylline (PTX) and then stimulated with P/I. Extracts were analysed by western blotting with the indicated antibodies. (C) EL-4 T cells were
either untreated or pre-treated with 6 mg/ml of pentoxifylline, then incubated with or without P/I for 4 h, as indicated. Nuclei were incubated with HinfI and the
genomic DNA was analysed by real-time PCR using primer setI. The mean and standard error of three replicate assays are shown. (D) GM-CSF mRNA levels were
determined by real-time PCR analysis of cDNA prepared from EL-4 T cells treated as in (C). Data were graphed as a fold change in the mRNA levels compared with
unstimulated, untreated cells. The mean and standard error of three replicate assays are shown. (E) CD4+ T cells isolated from wild-type or c-Rel/ mice were
incubated with P/I and anti-CD28 antibodies for 4 h, as indicated. Nuclei were incubated with HinfI and the genomic DNA was analysed by real-time PCR using
primer setI. Data were graphed as a relative accessibility compared to unstimulated wild-type T cells. The data from one representative experiment are shown. (F)
CD4+ T cells isolated from wild-type or c-Rel/ mice were incubated with anti-CD3 and anti-CD28 antibodies for 4 h, as indicated. Nuclei were incubated with
MNase and analysed as in (E).
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of a single nucleosome (9). We show here that the changes
in chromatin structure and GM-CSF gene transcription are
distinct molecular events, having different transcription factor
and signal requirements. Activation of the PKC signalling
pathway is both necessary and sufficient to induce changes
in chromatin accessibility at the GM-CSF promoter. The
PKC pathway may signal chromatin remodelling events at the
GM-CSF promoter in a number of ways. Transcription factors
activated via this pathway may bind to the GM-CSF promoter
and recruit chromatin remodelling activities, and there is evid-
ence to support such a mechanism. PKC signalling induces
nuclear expression of the NF-kB transcription factors, which
have been implicated in the induction of chromatin remodel-
ling events at the GM-CSF promoter, both here and in pre-
vious studies (9,22). In addition, the signals generated from
PKC mobilization may activate coactivators or remodelling
complexes required for GM-CSF promoter remodelling, or
alternatively may signal to histone proteins directly. In sup-
port of this mechanism, the transcriptional activation of the
LDL receptor via PKC signalling was recently found to cor-
relate with histone H3-Ser10 phosphorylation at the LDL
receptor gene (31). PKC was also found to phosphorylate
H3-Ser10 in vitro. Further studies are required to determine
whether chromatin remodelling events at the GM-CSF
promoter involve similar hyperphosphorylation of histone
proteins.
While the activation of the PKC signalling pathway is
sufficient to induce changes in the chromatin structure at
the GM-CSF promoter, additional signals generated by the
activation of intracellular calcium are required to induce
high levels of GM-CSF gene transcription. However, just
as changes in chromatin structure can be induced across the
GM-CSF promoter without significant gene transcription
occurring, transcriptional activation of the GM-CSF gene
can also be induced without any detectable changes in access-
ibility at the promoter. This suggests that the transcription
machinery can be assembled at the GM-CSF promoter and
drive transcription, at least at a low level, without reorganiza-
tion of the chromatin structure across the promoter. This indi-
cates that the mechanics of GM-CSF promoter activation are
different to a gene such as IFNb, where remodelling of a
nucleosome positioned over the TATA box is a prerequisite
for gene transcription (14,16) and may reflect the different
chromatin environment of the IFNb enhancer compared to
the GM-CSF promoter. Whereas the IFNb enhancer is
found in a nucleosome-free linker region and an adjacent
nucleosome must be remodelled to expose the TATA box
and enable transcription to occur (11,14), the GM-CSF prox-
imal promoter, and TATA box, appears to be assembled into a
nucleosome structure (9). However, even in resting T cells, the
GM-CSF promoter displays some inherent accessibility and
this may enable the transcription machinery to be recruited and
assembled at the promoter without significant changes to the
chromatin structure. Remodelling of the proximal promoter
region may be required for the binding of additional activators
to facilitate an efficient recruitment of the transcription
machinery and high-level gene transcription.
Chromatin remodelling of the GM-CSF promoter and gene
transcription also occurs with different kinetics following T
cell activation. While transcriptional activation occurs transi-
ently following stimulation, with the mRNA levels maximal at
6–8 h, the remodelled chromatin structure is relatively stable
in comparison and is maintained for several days. How the
remodelled chromatin structure is retained and whether it is
actively maintained or reset following cell division is unclear.
At least in EL-4 T cells, which undergo rapid cell division, the
maintenance of the remodelled state for up to 48 h following
stimulation would suggest that the remodelling is not auto-
matically reset during DNA replication, but is actively main-
tained through cell division. The stability of the remodelled
chromatin state is mirrored by the stable expression of the
NF-kB protein, c-Rel, in the nucleus, following stimu-
lation, and it is therefore possible that the remodelled state
is actively maintained as long as the c-Rel protein is present in
the nucleus.
The NF-kB proteins have been previously implicated in
chromatin remodelling events at the GM-CSF promoter
(9,22), and here, we have demonstrated a role for the c-Rel
protein in particular. From our data, it is clear that the presence
of c-Rel in the nucleus mirrors the chromatin remodelling
events at the promoter. The stability of the chromatin remod-
elling correlates with the stable nuclear accumulation of c-Rel,
while the prevention of nuclear accumulation of c-Rel with a
PKC inhibitor, pentoxifylline or cyclohexamide correlated
with the inhibition of chromatin remodelling. Furthermore,
the delayed depletion of c-Rel from the nucleus following
stimulus withdrawal correlated with the delayed return of
the promoter to a less accessible state. This correlation
between c-Rel and the chromatin remodelling events was veri-
fied by data from c-Rel/ mice. Stimulation of T cells from
c-Rel/ mice failed to induce changes in chromatin remod-
elling at the GM-CSF promoter. This is similar to chromatin
remodelling events at the IL-2 promoter, which have also been
found to be dependent on the c-Rel protein (32), but in contrast
to remodelling events at the IL-12 promoter for which c-Rel is
dispensable (33). It is not yet clear whether other NF-kB
family members also contribute to remodelling events. The
NF-kB family consists of five members; RelA, c-Rel, p50/
p105, p52/p100 and RelB. While the role of RelB in T cell
differentiation and activation is not well characterized, defects
in lymphocyte activation have been observed in knockout
mice of all the other family members [reviewed in (34)].
Since the other family members, particularly RelA and p50
have well-established roles in T cell activation, they may
contribute to the GM-CSF gene activation. Chromatin remod-
elling at the GM-CSF promoter was inhibited in cyclohexa-
mide-treated cells in which RelA but not c-Rel proteins were
present in the cell nucleus. This suggests that the RelA protein
alone is not sufficient to drive remodelling events. However,
this does not rule out the possibility that it may act in con-
junction with c-Rel to facilitate the chromatin remodelling, as
both these proteins bind to the CK-1 element in the GM-CSF
promoter at least in vitro (35). It is clear that the RelA family
member is required at least for subsequent transcriptional events
as microarray analysis of T cells from RelA/ mice revealed a
deficiency in GM-CSF gene activation (M. F. Shannon, un-
published data). In contrast to the NF-kB proteins, NFAT
proteins are dispensable for the chromatin remodelling events
at the GM-CSF promoter, but appear to cooperate with NF-kB
proteins to direct efficient GM-CSF gene transcription.
It is likely then that the activation of the GM-CSF gene
in response to T cell stimulation is a 2-step process in which
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the activation of the PKC signalling pathway results in the
accumulation of NF-kB proteins in the cell nucleus. The
inherent accessibility of nucleosomes across the promoter
region may allow the binding of NF-kB proteins without
prior remodelling events, and we have shown previously
that this can occur, at least in vitro (9). The NF-kB proteins
may then recruit chromatin remodelling activities such as the
SWI/SNF complex to increase the accessibility of the pro-
moter to other transcription factors. In support of this, we
have demonstrated that the brg1 protein is recruited to the
GM-CSF promoter in vitro, in an NF-kB dependent manner
(9). Increased accessibility of the promoter may then facilitate
binding of other transcription factors, such as NFAT, to enable
an efficient recruitment of the transcription machinery.
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